Related Articles
High mobility group AT‑hook 2 and c‑MYC as potential prognostic factors in pancreatic ductal adenocarcinoma
Latexin exhibits tumor-suppressor potential in pancreatic ductal adenocarcinoma
High HDAC9 is associated with poor prognosis and promotes malignant progression in pancreatic ductal adenocarcinoma
EGFR, but not COX‑2, protein in resected pancreatic ductal adenocarcinoma is associated with poor survival
High expression of RACK1 is associated with poor prognosis in patients with pancreatic ductal adenocarcinoma